Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M203,836Revenue (TTM) $M52,824Net Margin (%)13.5Altman Z-Score--
Enterprise Value $M203,836EPS (TTM) $1.2Operating Margin %26.0Piotroski F-Score--
P/E(ttm)29.0Beneish M-Score--Pre-tax Margin (%)15.8Higher ROA y-yN
Price/Book3.210-y EBITDA Growth Rate %1.3Quick Ratio--Cash flow > EarningsN
Price/Sales3.95-y EBITDA Growth Rate %-4.7Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow23.8y-y EBITDA Growth Rate %-9.9ROA % (ttm)4.2Higher Current Ratio y-yN
Dividend Yield %3.6PEG--ROE % (ttm)11.1Less Shares Outstanding y-yN
Payout Ratio %118Shares Outstanding M6,068ROIC % (ttm)13.8Gross Margin Increase y-yN

Gurus Latest Trades with PFE

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

PFE is held by these investors:



PFE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MADDALUNA ANTHONY JExecutive Vice President 2016-11-09Sell10,000$331.79view
BOURLA ALBERTGroup President 2016-11-04Sell18,390$30.0511.78view
DAMELIO FRANK AExecutive Vice President 2016-05-26Sell100,000$34.49-2.61view
CANGIALOSI LORETTA VSr. Vice President, Controller 2016-05-24Sell86,000$33.97-1.12view
OLSON LAURIE JExecutive Vice President 2016-05-11Sell4,700$33.50.27view
YOUNG JOHN DGroup President 2016-05-10Sell41,700$33.530.18view
DAMELIO FRANK AExecutive Vice President 2016-05-10Sell192,000$33.66-0.21view
READ IAN CChairman & CEO 2016-05-09Sell275,000$33.8-0.62view
SUSMAN SALLYExecutive Vice President 2016-05-09Sell67,884$33.71-0.36view
HILL CHARLES HExecutive Vice President 2016-05-09Sell29,600$33.84-0.74view

Quarterly/Annual Reports about PFE:

    News about PFE:

    Articles On GuruFocus.com
    Gilead Sciences Raises Dividend by Double Digits Feb 22 2017 
    Drug Addiction Treatment Stocks to Watch Feb 22 2017 
    David Tepper Invests Heavily in Pharma in 4th Quarter Feb 16 2017 
    Procter & Gamble, Pfizer Lead Market Gains Feb 16 2017 
    ANGEL Program Gets National Attention Feb 13 2017 
    US Market Indexes Regain Some of Their Losses on Wednesday Feb 02 2017 
    A Would-Be Dividend Aristocrat With a 3.5% Dividend Yield Jan 24 2017 
    US Market Indexes Lower on Monday Jan 24 2017 
    BioCorRx Receives New Funding for Opioid Drug Jan 22 2017 
    Forester Value Fund Quarterly Update Jan 10 2017 

    More From Other Websites
    Pfizer's Leukemia Candidate Gets Priority Review in U.S. Feb 22 2017
    Pfizer Inc. (PFE) Invest For Attractive Valuation And The 4% Dividend Yield Feb 22 2017
    Manufacturing Delay Of Generic Drug From Pfizer Inc. (PFE) A Relief For Teva Pharmaceutical... Feb 22 2017
    Goldman Says Buy Health-Care, Retail Volatility Before Trump Address Feb 22 2017
    Why Spark's CEO says 2017 may be a 'historic year' for his gene therapy company Feb 22 2017
    Merck & Co.’s Segment-Wise Revenues for 4Q16 Feb 22 2017
    World's Biggest Drugmaker Quits London and Swiss Listings Feb 22 2017
    Early movers: TOL, DISH, SIX, TRCO, FSLR, & more Feb 22 2017
    Viagra maker Pfizer cites poor performance for stock de-listing Feb 22 2017
    Pfizer Quits London and Swiss Listings, Says 'Limited Liquidity' in European Trading Feb 22 2017
    Momenta, Pfizer Give Teva Pharma Breathing Room On Generic MS Drug Feb 21 2017
    Here’s What The Latest Pain Therapeutics, Inc. (PTIE) Update Means Feb 21 2017
    Boeing, GE and Oracle CEOs Support Border Adjustment Tax in Letter to Congress Feb 21 2017
    Execs from Boeing, Pfizer Send Letter Backing House GOP Tax Plan Feb 21 2017
    8:02 am Pfizer announces that a BLA for inotuzumab ozogamicin has been accepted for filing and... Feb 21 2017
    Pfizer Announces Acceptance of Regulatory Submission for Inotuzumab Ozogamicin by the U.S. Food and... Feb 21 2017
    New Data in Crohn’s Disease Patients Shows Similar Efficacy and Safety Profiles for INFLECTRA®... Feb 17 2017
    UK agency says Pfizer breast cancer drug too expensive Feb 02 2017
    Pfizer hires JPMorgan to weigh sale of some drugs - Bloomberg Feb 02 2017
    Business Highlights Jan 31 2017
    Pfizer swings to 4Q profit after rough year, hikes 2017 view Jan 31 2017
    Pfizer's profit misses as Prevnar sales lag, costs rise Jan 31 2017
    Pfizer's profit misses as Prevnar sales lag, costs rise Jan 31 2017
    Pfizer Receives Positive CHMP Opinion in Europe for XELJANZ® (tofacitinib citrate) for the... Jan 27 2017
    J&J to spend $30 billion on Swiss drugmaker Actelion Jan 26 2017
    Johnson & Johnson cautious in outlook, shops diabetes care Jan 24 2017
    Sanofi's M&A misses frustrate some investors in drugmaker Jan 20 2017
    INSIGHT: Sanofi's M&A misses frustrate some investors in drugmaker Jan 20 2017
    INSIGHT: Sanofi's M&A misses frustrate some investors in drugmaker Jan 20 2017
    How to improve your sex life without breaking the bank Jan 18 2017
    Markets Right Now: Stocks end a wobbly day with solid gains Jan 11 2017
    US warns of unusual cybersecurity flaw in heart devices Jan 10 2017
    Pfizer Announces Positive Top-Line Results from the Comparative REFLECTIONS B538-02 Study for... Jan 05 2017
    BAT quits nicotine inhaler to focus on vaping Jan 05 2017
    Pfizer Invites Public To View And Listen To Webcast Of January 31 Conference Call With Analysts Jan 03 2017
    Growth hormone deficiency drug from OPKO and Pfizer fails study Dec 30 2016
    Growth hormone deficiency drug from OPKO and Pfizer fails study Dec 30 2016
    Pfizer Completes Acquisition of Small Molecule Anti-Infective Business From AstraZeneca Dec 23 2016
    Markets Right Now: Health care stocks lead US indexes lower Dec 21 2016
    FDA Accepts Supplemental New Drug Application for Pfizer’s IBRANCE® (palbociclib) in HR+, HER2-... Dec 21 2016
    Actelion shares gain on report of progress in Sanofi talks Dec 21 2016
    BioInvent announces Cancer Immunotherapy Research Collaboration and License Agreement with Pfizer... Dec 21 2016
    Pfizer Receives Approval in the European Union for Nimenrix™ (Meningococcal Group A, C, W-135, and... Dec 19 2016
    US drops bold warning from anti-smoking pills Chantix, Zyban Dec 16 2016
    FDA Approves Removal Of Boxed Warning Regarding Serious Neuropsychiatric Events From CHANTIX®... Dec 16 2016
    Actavis UK accused of overcharging hydrocortisone drug Dec 16 2016
    Firm accused of overcharging NHS by hiking life-saving drug price by 12,000% Dec 16 2016
    Drugmakers set to gain as taxpayers foot new opioid costs Dec 15 2016
    Drugmakers push profitable, but unproven, opioid solution Dec 15 2016
    Pfizer and Astellas Announce Top-Line Results from Phase 4 PLATO Trial of XTANDI® (enzalutamide)... Dec 14 2016
    Britain fines Pfizer record $107 mln for huge drug price hike Dec 07 2016
    Pfizer and Flynn Pharma fined over 2,600% NHS price hike Dec 07 2016
    Britain fines Pfizer record $107 mln for huge drug price hike Dec 07 2016
    Drug firms fined over 2,600% NHS price hike for epilepsy treatment Dec 07 2016
    Drug firms fined £90m for 'excessive' price hike to NHS Dec 07 2016
    Britain fines Pfizer record $107 mln for huge drug price hike Dec 07 2016
    Dealtalk: Trump's corporate tax holiday could spur pharma M&A Dec 06 2016
    Pfizer Announces Positive Top-Line Results from the Pivotal Comparative REFLECTIONS B3271002 Study... Dec 01 2016
    LYRICA® (pregabalin) Phase 3 Trial in Pediatric Epilepsy Meets Primary Endpoint Dec 01 2016
    IBM and Pfizer to Accelerate Immuno-oncology Research with Watson for Drug Discovery Dec 01 2016
    Pfizer Announces Expiration And Results Of Tender Offer For Any And All Of Its 6.200% Senior Notes... Nov 21 2016
    Anthony J. Maddaluna, Executive Vice President and President of Pfizer Global Supply to Retire Nov 21 2016
    Pfizer Announces Pricing of Tender Offer for Any and All of its 6.200% Senior Notes Due March 15,... Nov 18 2016
    Pfizer Announces Results from Phase 3 OPAL Clinical Development Program Investigating XELJANZ®... Nov 15 2016
    Pfizer Prices $6,000,000,000 Debt Offering Nov 15 2016
    Pfizer Announces Tender Offer for Any and All of its 6.200% Senior Notes Due March 15, 2019 Nov 14 2016
    Pfizer offers cut-price pneumonia shot for humanitarian crises Nov 11 2016
    Pfizer offers cut-price pneumonia shot for humanitarian crises Nov 11 2016
    Pfizer Announces Major Expansion of Humanitarian Assistance Program Nov 11 2016
    Dow hits new record as Trump victory drives up blue chips Nov 10 2016
    Bristol-Myers Squibb and Pfizer to Deliver 12 New Eliquis® (apixaban) Presentations at American... Nov 10 2016
    IBRANCE® (palbociclib) Receives Approval in European Union for the Treatment of Women with... Nov 10 2016
    IBRANCE® (palbociclib) Receives Approval in European Union for the Treatment of Women with... Nov 10 2016
    Novartis, Pfizer cut prices to win UK approval for cancer drugs Nov 09 2016
    Viagra maker Pfizer denies Brexit link to two UK site closures Nov 08 2016
    Pfizer denies Brexit link to two UK site closures Nov 08 2016
    Pfizer says closing two British sites, not Brexit-related Nov 08 2016
    US STOCKS-U.S. election, rate uncertainty rattle Wall Street Nov 01 2016
    Pfizer cholesterol drug fizzles, hitting shares Nov 01 2016
    US STOCKS-Wall St shaken by U.S. election, rate uncertainty Nov 01 2016
    US STOCKS-Wall St rattled by U.S. election, rate uncertainty Nov 01 2016
    Advent, Bain gain edge in bid for Pfizer's Brazil venture - sources Oct 21 2016
    Pfizer decides against split-up; more deals seen likely Sep 26 2016
    Pfizer boosts cancer drug roster with $14 billion Medivation deal Aug 22 2016
    Wall Street falls as weak auto sales spur growth jitters Aug 02 2016
    Teva, Mylan eye Pfizer's Brazil venture, sources say Jul 26 2016
    Pfizer to buy Anacor in $5.2 billion deal for access to eczema gel May 16 2016
    EXCLUSIVE: Pfizer approaches Medivation about potential takeover -sources May 03 2016
    Investors stick with Pfizer CEO after Allergan deal scrapped Apr 07 2016
    Pfizer, Allergan scrap $160 billion deal after U.S. tax rule change Apr 06 2016
    Obama's inversion curbs kill Pfizer's $160 bln Allergan deal Apr 06 2016
    Obama's inversion curbs kill Pfizer's $160 billion Allergan deal Apr 06 2016
    Pfizer, Allergan to mutually terminate merger on Wednesday morning, source says Apr 05 2016
    Delhi High Court grants Pfizer temporary relief on cough syrup ban Mar 14 2016
    Delhi High Court grants Pfizer temporary relief on cough syrup ban Mar 14 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)